Novartis Settles US Exforge Case For $245m

Originator Had Been Accused Of Unlawful Deal With Par To Maintain Monopoly

 
• By David Wallace
  
Exforge pack Novartis
Novartis and Par had been accused of an anti-competitive deal over Exforge • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin